Skip to main content

Research Repository

Advanced Search

Large-scale statistical analysis of Mycobacterium tuberculosis genome sequences identifies compensatory mutations associated with multi-drug resistance

Billow, Nina; Phelan, Jody; Xia, Dong; Peng, Yonghong; Clark, Taane G.; Chang, Yu-Mei

Authors

Nina Billow

Jody Phelan

Dong Xia

Yonghong Peng

Taane G. Clark

Yu-Mei Chang



Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis, has a significant impact on global health worldwide. The development of multi-drug strains that are resistant to the first-line drugs isoniazid and rifampicin threatens public health security. Rifampicin and isoniazid resistance are largely underpinned by mutations in rpoB and katG respectively and are associated with fitness costs. Compensatory mutations are considered to alleviate these fitness costs and have been observed in rpoC/rpoA (rifampicin) and oxyR’-ahpC (isoniazid). We developed a framework (CompMut-TB) to detect compensatory mutations from whole genome sequences from a large dataset comprised of 18,396 M. tuberculosis samples. We performed association analysis (Fisher’s exact tests) to identify pairs of mutations that are associated with drug-resistance, followed by mediation analysis to identify complementary or full mediators of drug-resistance. The analyses revealed several potential mutations in rpoC (N=47), rpoA (N=4), and oxyR’-ahpC (N=7) that were considered either ‘highly likely’ or ‘likely’ to confer compensatory effects on drug-resistance, including mutations that have previously been reported and validated. Overall, we have developed the CompMut-TB framework which can assist with identifying compensatory mutations which is important for more precise genome-based profiling of drug-resistant TB strains and to further understanding of the evolutionary mechanisms that underpin drug-resistance.

Citation

Billow, N., Phelan, J., Xia, D., Peng, Y., Clark, T. G., & Chang, Y.-M. (in press). Large-scale statistical analysis of Mycobacterium tuberculosis genome sequences identifies compensatory mutations associated with multi-drug resistance. Scientific Reports, https://doi.org/10.1038/s41598-024-62946-8

Journal Article Type Article
Acceptance Date May 22, 2024
Online Publication Date May 29, 2024
Deposit Date Aug 28, 2024
Publicly Available Date Aug 29, 2024
Electronic ISSN 2045-2322
Publisher Nature Research
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1038/s41598-024-62946-8
Publisher URL https://doi.org/10.1038/s41598-024-62946-8

Files




You might also like



Downloadable Citations